Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer

To date, many different chemotherapeutic agents have been widely used as common treatments for oral cancers. However, their therapeutic effects have been disappointing, and these agents may have unwanted side effects. Among the many regulatory factors, overexpression of pro-survival Bcl-2 family mem...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Ji-Ae, Kim, Lee-Han, Lee, Sook-Jeong, Jeong, Joseph H., Jung, Ji-Youn, Lee, Hae Nim, Hong, In-Sun, Cho, Sung-Dae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742133/
https://www.ncbi.nlm.nih.gov/pubmed/26447615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742133/
https://www.ncbi.nlm.nih.gov/pubmed/26447615

Ejemplares similares